{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:33:25Z","timestamp":1786120405376,"version":"build-2736575974"},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Neuropharmacology"],"published-print":{"date-parts":[[1992]]},"DOI":"10.1097\/00002826-199201001-00192","type":"journal-article","created":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T06:33:12Z","timestamp":1328077992000},"page":"370A-371A","source":"Crossref","is-referenced-by-count":0,"title":["CROSS-SECTIONAL PHASE OF THE WHO NEUROPSYCHIATRIC AIDS STUDY: RESULTS OF COGNITIVE\/NEUROPSYCHOLOGICAL ASSESSMENT"],"prefix":"10.1097","volume":"15","author":[{"given":"M.","family":"MAJ","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"STARACE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002826-199201001-00192","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:39:24Z","timestamp":1786048764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002826-199201001-00192"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[1992]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1097\/00002826-199201001-00192","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[1992]]}}}